Fidelity International’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261M Buy
531,867
+3,145
+0.6% +$1.71M 0.2% 125
2025
Q4
$306M Buy
528,722
+131,724
+33% +$74.5M 0.23% 115
2025
Q3
$193M Buy
396,998
+26,933
+7% +$12.5M 0.15% 163
2025
Q2
$150M Sell
370,065
-92,087
-20% -$38.5M 0.13% 176
2025
Q1
$230M Buy
462,152
+115,013
+33% +$62.3M 0.22% 126
2024
Q4
$181M Buy
347,139
+128,095
+58% +$70.4M 0.17% 152
2024
Q3
$135M Sell
219,044
-9,757
-4% -$5.78M 0.12% 192
2024
Q2
$127M Sell
228,801
-67,039
-23% -$38.4M 0.13% 191
2024
Q1
$172M Sell
295,840
-119,440
-29% -$67M 0.17% 151
2023
Q4
$220M Buy
415,280
+8,431
+2% +$4.08M 0.23% 116
2023
Q3
$206M Sell
406,849
-64,500
-14% -$34.4M 0.24% 122
2023
Q2
$246M Buy
471,349
+33,258
+8% +$17.9M 0.28% 105
2023
Q1
$253M Buy
438,091
+9,143
+2% +$5.15M 0.29% 98
2022
Q4
$236M Buy
428,948
+3,344
+0.8% +$1.77M 0.28% 94
2022
Q3
$216M Sell
425,604
-1,423
-0.3% -$796K 0.28% 92
2022
Q2
$232M Sell
427,027
-18,515
-4% -$10.2M 0.28% 97
2022
Q1
$263M Sell
445,542
-140,362
-24% -$80.6M 0.27% 101
2021
Q4
$391M Sell
585,904
-39,371
-6% -$24.6M 0.4% 62
2021
Q3
$357M Buy
625,275
+55,526
+10% +$30.5M 0.4% 63
2021
Q2
$287M Buy
569,749
+12,810
+2% +$6.04M 0.31% 73
2021
Q1
$254M Sell
556,939
-86,969
-14% -$41.5M 0.29% 85
2020
Q4
$300M Buy
643,908
+230,381
+56% +$108M 0.37% 60
2020
Q3
$183M Buy
413,527
+116,742
+39% +$48.2M 0.23% 120
2020
Q2
$108M Buy
296,785
+66,945
+29% +$22.4M 0.15% 166
2020
Q1
$65.2M Sell
229,840
-1,425
-0.6% -$449K 0.11% 188
2019
Q4
$75.1M Sell
231,265
-375,741
-62% -$114M 0.1% 209
2019
Q3
$177M Buy
607,006
+129,176
+27% +$37M 0.27% 95
2019
Q2
$140M Buy
477,830
+27,142
+6% +$7.48M 0.21% 127
2019
Q1
$123M Buy
450,688
+300,199
+199% +$74.7M 0.19% 133
2018
Q4
$33.7M Sell
150,489
-15,207
-9% -$3.57M 0.06% 279
2018
Q3
$40.4M Buy
165,696
+5,314
+3% +$1.22M 0.06% 292
2018
Q2
$33.2M Buy
160,382
+10,261
+7% +$2.18M 0.05% 309
2018
Q1
$31M Buy
150,121
+1,702
+1% +$357K 0.09% 208
2017
Q4
$28.2M Buy
+148,419
New +$28.4M 0.08% 218
2017
Q1
Sell
-45,758
Closed -$6.46M 544
2016
Q4
$6.46M Sell
45,758
-1,218
-3% -$180K 0.02% 374
2016
Q3
$7.47M Sell
46,976
-845
-2% -$130K 0.02% 357
2016
Q2
$7.07M Buy
47,821
+4,539
+10% +$670K 0.02% 362
2016
Q1
$6.13M Sell
43,282
-2,595
-6% -$348K 0.02% 365
2015
Q4
$6.51M Sell
45,877
-145,409
-76% -$19.4M 0.02% 360
2015
Q3
$23.4M Sell
191,286
-45,264
-19% -$5.9M 0.08% 223
2015
Q2
$30.7M Buy
236,550
+49,147
+26% +$6.41M 0.1% 195
2015
Q1
$25.2M Buy
187,403
+66,310
+55% +$8.55M 0.08% 233
2014
Q4
$15.2M Buy
121,093
+27,682
+30% +$3.37M 0.05% 296
2014
Q3
$11.4M Buy
93,411
+47,869
+105% +$5.82M 0.04% 316
2014
Q2
$5.37M Sell
45,542
-30,355
-40% -$3.57M 0.02% 398
2014
Q1
$9.13M Buy
75,897
+55,567
+273% +$6.61M 0.03% 350
2013
Q4
$2.26M Sell
20,330
-13,420
-40% -$1.33M 0.01% 440
2013
Q3
$3.11M Buy
33,750
+5,010
+17% +$453K 0.01% 413
2013
Q2
$2.43M Buy
+28,740
New +$2.39M 0.01% 396

Other funds holding TMO

Fidelity International's TMO Position: Q1 2026 in Review

Fidelity International increased its Thermo Fisher Scientific (TMO) stake by 0.59% in Q1 2026, buying an estimated $1.71M and bringing the position to 531,867 shares worth $261M. The position accounts for 0.2% of the portfolio, ranked #125.

Fidelity International first reported a position in TMO in Q2 2013 and has held it in 49 quarters since. The position peaked at $391M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fidelity International held 531,867 shares of Thermo Fisher Scientific worth $261M as of Q1 2026.
  • Fidelity International bought 3,145 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.71M.
  • Thermo Fisher Scientific made up 0.2% of Fidelity International's portfolio in Q1 2026, its #125 holding.
  • Fidelity International first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 49 quarters since.
  • Fidelity International's Thermo Fisher Scientific position peaked at $391M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.